A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patients. by Timothy J Molloy, Paul Roepman, Bjørn Naume, Laura J van't Veer

Get full text

Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma. by Patti Curl, Igor Vujic, Laura J van 't Veer, Susana Ortiz-Urda, James G Kahn

Get full text

Correction: Cost-Effectiveness Of Treatment Strategies for BRAF-Mutated Metastatic Melanoma. by Patti Curl, Igor Vujic, Laura J van 't Veer, Susana Ortiz-Urda, James G Kahn

Get full text

Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity. by Denise M Wolf, Marc E Lenburg, Christina Yau, Aaron Boudreau, Laura J van 't Veer

Get full text

Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy by Mark Jesus M. Magbanua, Ozge Gumusay, Razelle Kurzrock, Laura J. van ‘t Veer, Hope S. Rugo

Get full text

Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance by Pavel Stejskal, Hani Goodarzi, Josef Srovnal, Marián Hajdúch, Laura J. van ’t Veer, Mark Jesus M. Magbanua

Get full text

Biological Functions of the Genes in the Mammaprint Breast Cancer Profile Reflect the Hallmarks of Cancer by Sun Tian, Paul Roepman, Laura J van't Veer, Rene Bernards, Femke De Snoo, Annuska M Glas

Get full text

Biological Functions of the Genes in the Mammaprint Breast Cancer Profile Reflect the Hallmarks of Cancer by Annuska M Glas, Paul Roepman, Laura J van’t Veer, Rene Bernards, Femke de Snoo, Sun Tian

Get full text

Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis. by Alexandra J van den Broek, Marjanka K Schmidt, Laura J van 't Veer, Rob A E M Tollenaar, Flora E van Leeuwen

Get full text

Circulating tumor cells in early lobular versus ductal breast cancer and their associations with prognosis by Silver Alkhafaji, Denise M. Wolf, Mark Jesus M. Magbanua, Laura J. van ‘t Veer, John W. Park, Laura Esserman, Rita A. Mukhtar

Get full text

Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissue. by Lorenza Mittempergher, Jorma J de Ronde, Marja Nieuwland, Ron M Kerkhoven, Iris Simon, Emiel J Th Rutgers, Lodewyk F A Wessels, Laura J Van't Veer

Get full text

Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy by Ella F. Jones, Deep K. Hathi, Rita Freimanis, Rita A. Mukhtar, A. Jo Chien, Laura J. Esserman, Laura J. van’t Veer, Bonnie N. Joe, Nola M. Hylton

Get full text

Prognostic Value of MammaPrint® in Invasive Lobular Breast Cancer by Inès J. Beumer, Marion Persoon, Anke Witteveen, Christa Dreezen, Suet-Feung Chin, Stephen-John Sammut, Mireille Snel, Carlos Caldas, Sabine Linn, Laura J. van 't Veer, Rene Bernards, Annuska M. Glas

Get full text

Prognostic Value of MammaPrint in Invasive Lobular Breast Cancer by Inès J. Beumer, Marion Persoon, Anke Witteveen, Christa Dreezen, Suet-Feung Chin, Stephen-John Sammut, Mireille Snel, Carlos Caldas, Sabine Linn, Laura J. van 't Veer, Rene Bernards, Annuska M. Glas

Get full text

Radiomic tumor phenotypes augment molecular profiling in predicting recurrence free survival after breast neoadjuvant chemotherapy by Rhea Chitalia, Marios Miliotis, Nariman Jahani, Spyros Tastsoglou, Elizabeth S. McDonald, Vivian Belenky, Eric A. Cohen, David Newitt, Laura J. van’t Veer, Laura Esserman, Nola Hylton, Angela DeMichele, Artemis Hatzigeorgiou, Despina Kontos

Get full text

An information-theoretic analysis of genetics, gender and age in cancer patients. by Gurinder Singh Atwal, Raúl Rabadán, Guillermina Lozano, Louise C Strong, Mariëlle W G Ruijs, Marjanka K Schmidt, Laura J van't Veer, Heli Nevanlinna, Johanna Tommiska, Kristiina Aittomäki, Gaelle Bougeard, Thierry Frebourg, Arnold J Levine, Gareth L Bond

Get full text

B-cells and regulatory T-cells in the microenvironment of HER2+ breast cancer are associated with decreased survival: a real-world analysis of women with HER2+ metastatic breast ca... by Tessa G. Steenbruggen, Denise M. Wolf, Michael J. Campbell, Joyce Sanders, Sten Cornelissen, Bram Thijssen, Roberto A. Salgado, Christina Yau, Nick O-Grady, Amrita Basu, Rajith Bhaskaran, Lorenza Mittempergher, Gillian L. Hirst, Jean-Philippe Coppe, Marleen Kok, Gabe S. Sonke, Laura J. van ‘t Veer, Hugo M. Horlings

Get full text

Circadian PERformance in breast cancer: a germline and somatic genetic study of PER3 VNTR polymorphisms and gene co-expression by Jaume Fores-Martos, Raimundo Cervera-Vidal, Julia Sierra-Roca, Carlos Lozano-Asencio, Vita Fedele, Sten Cornelissen, Hege Edvarsen, Irene Tadeo-Cervera, Pilar Eroles, Ana Lluch, Rafa Tabares-Seisdedos, Antonio Falcó, Laura J. Van’t Veer, Marjanka Schmidt, David A. Quigley, Anne-Lise Børresen-Dale, Vessela N. Kristensen, Allan Balmain, Joan Climent

Get full text

Elevated risk thresholds predict endocrine risk-reducing medication use in the Athena screening registry by Yash S. Huilgol, Holly Keane, Yiwey Shieh, Robert A. Hiatt, Jeffrey A. Tice, Lisa Madlensky, Leah Sabacan, Allison Stover Fiscalini, Elad Ziv, Irene Acerbi, Mandy Che, Hoda Anton-Culver, Alexander D. Borowsky, Sharon Hunt, Arash Naeim, Barbara A. Parker, Laura J. van ‘T Veer, Athena Breast Health Network Investigators and Advocate Partners, Laura J. Esserman

Get full text

Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer by Joyce V. Lee, Filomena Housley, Christina Yau, Rachel Nakagawa, Juliane Winkler, Johanna M. Anttila, Pauliina M. Munne, Mariel Savelius, Kathleen E. Houlahan, Daniel Van de Mark, Golzar Hemmati, Grace A. Hernandez, Yibing Zhang, Susan Samson, Carole Baas, Laura J. Esserman, Laura J. van ‘t Veer, Hope S. Rugo, Christina Curtis, Juha Klefström, Mehrdad Matloubian, Andrei Goga

Get full text